Summary
The product Accutane 40 mg, submitted by MuscleCandy and identified by batch number Lot1001, underwent independent testing by Janoshik Analytical. The analysis measured the concentration of Isotretinoin, which was found to be 39.46 mg per capsule, closely matching the labeled claim of 40 mg.
The testing process began on 19 April 2024, with the sample received on 24 April 2024, and analysis completed on 26 April 2024. These results highlight the importance of independent verification to ensure accurate dosing. Continued scrutiny and comprehensive testing are essential for maintaining quality assurance in the pharmaceutical market.
Detailed Report
Product Overview
- Manufacturer: Muscle Candy
- Product Name: Accutane 40 mg
- Active Ingredient: Isotretinoin
- Batch Number: Lot1001
- Expiration Date: Not provided
- Delivery Method: Oral capsule
Sample Acquisition and Testing
- Task Number: #41412
- Testing Ordered: 19 April 2024
- Sample Received: 24 April 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: MuscleCandy
- Analysis Paid For By: MuscleCandy
Testing Results
- Specification: 40 mg (as stated on the label)
- Measured Concentration: 39.46 mg
- Accuracy: 98.65% (1.35% below the label claim)
- Variance: -1.35%
Verification Details
- Verification URL: https://janoshik.com/tests/41412_5LAJGWMQDR2W
Evaluation of Reseller-Submitted Testing
The analysis shows that the tested batch of Accutane 40 mg contains a concentration very close to the labeled dosage. While this suggests strong quality control for this batch, it is important to approach reseller-submitted results with caution. Resellers may submit high-quality batches for testing, which may not fully represent product consistency across the market. Independent validation through testing multiple batches would provide a more comprehensive assessment.
Conclusion
The analysis confirms that the tested batch of Accutane 40 mg contains 39.46 mg of Isotretinoin, indicating accurate dosing. This result underscores the importance of third-party testing for quality assurance and informed decision-making regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
